Loading...

DIVISLAB Divi's Laboratories Ltd Management Changes Announcement

Dv's

DVSL

Divi's Laboratories Ltd

(DIVISLAB)

2025 Announcement

Show Summary

Show Summary

Tax Deduction Info

Equity Shares Transfer

Long-Term Agreement

Earnings Call Summary

Financial Results Publication

Q4 FY25 Earnings Call

Secretarial Auditor Appoint...

Management Change

Annual Compliance Report

Earnings Call Scheduled

Management Change

Long-Term Agreement

Regulatory Compliance

Management Change

Earnings Call Transcript

Postal Ballot Notice

Financial Results Published

Earnings Call Audio

Management Changes

Director Reappointment

Earnings Call Scheduled

Compliance Submission

New Operations Launched

Penalty Disclosure

Media Report Clarification

Regulatory Penalty Issued

Earnings Call Transcript

Financial Results

Earnings Call Audio

Earnings Call Scheduled

Earnings Call Schedule

Compliance Submission

Credit Rating Reaffirmed

Earnings Call Transcript

Financial Results Publication

Earnings Conference Call In...

Certificate Submission

Notice Publication

Newspaper Clippings

Director Cessation

Deduction of Tax from Divid...

Earnings Call Transcript

Financial Results Publication

Compliance Amendment

Board Meeting Outcome

Compliance Submission

Earnings Conference Call

Capacity Addition

Certificate Submission

Compliance Certificate Subm...

Certificate Submission

Newspaper Publication

Newspaper Publication

Earnings Call Transcript

Financial Results Publication

Earnings Call Audio Uploaded

Management Appointments

Earnings Conference Call

Submission of Certificate u...

GST Order Update

Disclosure Order

Regulatory Action

Financial Results Publication

Earnings Call Transcript

Earnings Conference Call

Submission of Certificate

USFDA Visits Divis Choutupp...

USFDA Delegation Visit

Visit by USFDA Delegation

Resignation of Director

Financial Statements

Financial Statements

Earnings Guidance

Policy Amendment

Financial Statements, Earni...

Newspaper Publication

Financial Statements, Earni...

Financial Statements

Earnings Call Transcript

Management Changes

Publishing of Newspaper cli...

Dividend Disclosure

Earnings Call Transcript Up...

Financial Statements

Earnings Conference Call

External Links:

Data:

Divi's Laboratories reappoints Dr. Kiran S. Divi as Whole-time Director and CEO for 5 years starting April 1, 2025, pending member approval. The board also approved unaudited financial results for the nine months ending December 31, 2024.

AI Assistant

Divi's Laboratories Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.